rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2010-8-16
|
pubmed:abstractText |
Donor-derived transmission of hepatitis B virus (HBV) may cause serious complications after transplantation. To date, transplantation from HBV-infected donors to HBV-infected recipients seems feasible, although this is recommended with prophylaxis with specific drugs and antibodies only, whereas pre-emptive strategies are rarely used.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1873-5967
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright (c) 2010 Elsevier B.V. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
49
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
53-7
|
pubmed:meshHeading |
pubmed-meshheading:20656549-Adult,
pubmed-meshheading:20656549-DNA, Viral,
pubmed-meshheading:20656549-Female,
pubmed-meshheading:20656549-Hepatitis B,
pubmed-meshheading:20656549-Hepatitis B Antibodies,
pubmed-meshheading:20656549-Hepatitis B virus,
pubmed-meshheading:20656549-Humans,
pubmed-meshheading:20656549-Immunity, Cellular,
pubmed-meshheading:20656549-Kidney Transplantation,
pubmed-meshheading:20656549-Liver,
pubmed-meshheading:20656549-Male,
pubmed-meshheading:20656549-Middle Aged,
pubmed-meshheading:20656549-Tissue Donors,
pubmed-meshheading:20656549-Treatment Outcome,
pubmed-meshheading:20656549-Viral Load
|
pubmed:year |
2010
|
pubmed:articleTitle |
Successful outcome of kidney transplantation from a HBV-DNA positive donor into recipients with cleared HBV-infection using a pre-emptive therapy approach.
|
pubmed:affiliation |
Department of Transplant and Infection Immunology, Institute of Virology, Saarland University, D-66421 Homburg, Germany.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|